Identification of Risk of Cardiovascular Disease by Automatic Quantification of Coronary Artery Calcifications on Radiotherapy Planning CT Scans in Patients with Breast Cancer

Autor: Pim A. de Jong, Roxanne Gal, Ilonca Vaartjes, Femke van der Leij, Julia J. van Tol-Geerdink, Desirée H.J.G. van den Bongard, Sanne G. M. van Velzen, Erwin L. A. Blezer, M.L. Gregorowitsch, Arco J. Teske, M.G.A. Sattler, Tim Leiner, Sofie A. M. Gernaat, Jean-Philippe Pignol, Maartje J. Hooning, Nikolas Lessmann, J. Penninkhof, Ivana Išgum, Marleen J. Emaus, J. Verloop, Helena M. Verkooijen, H. Meijer

Publikováno v: JAMA Oncology, 7(7), 1024-1032. American Medical Association
JAMA Oncol
Jama Oncology, 7, 7, pp. 1024-1032
Jama Oncology, 7, 1024-1032
JAMA oncology, 7(7), 1024-1032. American Medical Association

Contains fulltext : 235298.pdf (Publisher’s version ) (Open Access) Importance: Cardiovascular disease (CVD) is common in patients treated for breast cancer, especially in patients treated with systemic treatment and radiotherapy and in those with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c12abc696299924312684ebd7e9fd3
http://www.scopus.com/inward/record.url?scp=85105858822&partnerID=8YFLogxK

Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty?

Autor: L. M. van Maurik, D. Raphael, Liesbeth J. Boersma, M.G.A. Sattler, M.R. Stam, John H. Maduro, P.G. Westhoff, J.M. Immink, M.C. Stenfert Kroese, Nicola S. Russell, T. van der Weijden, H.J.G.D. Van den Bongard

Publikováno v: Breast, 51, 105-113. Churchill Livingstone
The Breast, 51, 105-113. CHURCHILL LIVINGSTONE
The Breast : official journal of the European Society of Mastology
The Breast, 51, 105-113. Churchill Livingstone
Breast, 51, 105-113
Breast, Vol 51, Iss, Pp 105-113 (2020)
Breast, 51, pp. 105-113
Breast, 51(1), 105-113. Churchill Livingstone

Background and aim Patient decision aids for oncological treatment options, provide information on the effect on recurrence rates and/or survival benefit, and on side-effects and/or burden of different treatment options. However, often uncertainty ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c2c553fee3063f83e89053c85e9df59
https://doi.org/10.1016/j.breast.2020.04.001

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial

Autor: M.G.A. Sattler, Jean-Philippe Pignol, Eileen Rakovitch, Ivo A. Olivotto, Timothy J. Whelan, Pauline T. Truong

Publikováno v: Radiotherapy and Oncology, 121(3), 414-419. Elsevier Ireland Ltd

Background and purpose: We report the long-term outcomes in patients enrolled in a multicenter randomized controlled trial comparing Intensity Modulated Radiation Therapy (IMRT) with standard wedge radiotherapy. Materials and methods: Trial participa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b936c1594bf33e0f09823238e25183b
https://doi.org/10.1016/j.radonc.2016.08.021